You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 579 Novel digital image approach of multiplex immunofluorescence based PD-L1 expression enables the stratification of advanced NSCLC patients treated with durvalumab

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials Completed
579 Novel digital image approach of multiplex immunofluorescence based PD-L1 expression enables the stratification of advanced NSCLC patients treated with durvalumab
Free

 

Online download statistics by month:

Online download statistics by month: December 2022 to August 2024

AbstractFullPdf
Dec 20225408
Jan 20233604
Feb 20235406
Mar 20233802
Apr 20232402
May 20232000
Jun 20232805
Jul 20231803
Aug 20232404
Sep 2023802
Oct 20231802
Nov 20232003
Dec 20235005
Jan 20241401
Feb 202446064
Mar 20243403
Apr 20244603
May 20241801
Jun 20241403
Jul 20247001
Aug 20243005
Total6640127